Modification of yeast uricase with polyethylene glycol: disappearance of binding ability towards anti-uricase serum
- PMID: 573687
- DOI: 10.1159/000458668
Modification of yeast uricase with polyethylene glycol: disappearance of binding ability towards anti-uricase serum
Abstract
Uricase from Candida utilis was modified with activated polyethylene glycol (2-O-methoxypolyethylene glycol-4,6-dichloro-s-triazine) of molecular weight of 5,000 daltons. The modification of 43% of the total amino groups in the uricase molecule gave rise to a complete loss of the binding ability towards anti-uricase serum from rabbit. This modified uricase retained 15% of the enzymic activity of non-modified uricase.
Similar articles
-
Improved modification of yeast uricase with polyethylene glycol, accompanied with nonimmunoreactivity towards anti-uricase serum and high enzymic activity.Enzyme. 1981;26(1):49-53. doi: 10.1159/000459146. Enzyme. 1981. PMID: 7194181
-
Studies on antigenicity of the polyethylene glycol (PEG)-modified uricase.Int J Immunopharmacol. 1985;7(5):725-30. doi: 10.1016/0192-0561(85)90158-4. Int J Immunopharmacol. 1985. PMID: 2412977
-
Modification with polysialic acid-PEG copolymer as a new method for improving the therapeutic efficacy of proteins.Prep Biochem Biotechnol. 2016 Nov 16;46(8):788-797. doi: 10.1080/10826068.2015.1135463. Prep Biochem Biotechnol. 2016. PMID: 26829568
-
Pegloticase, a polyethylene glycol conjugate of uricase for the potential intravenous treatment of gout.Curr Opin Investig Drugs. 2008 Apr;9(4):422-9. Curr Opin Investig Drugs. 2008. PMID: 18393109 Review.
-
PEG-uricase in the management of treatment-resistant gout and hyperuricemia.Adv Drug Deliv Rev. 2008 Jan 3;60(1):59-68. doi: 10.1016/j.addr.2007.06.011. Epub 2007 Aug 14. Adv Drug Deliv Rev. 2008. PMID: 17826865 Review.
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources